Pfizer Limited was listed on the Bombay stock exchange in 1966. Today, the company has over one lakh shareholders in India. With annual sales of over Rs. 2,000 crores, it is the fourth largest multinational pharmaceutical company in India. The Company has a portfolio of over 150 products across 15 therapeutic areas. Our relentless focus on research and development, combined with cutting-edge technology and rigorous safety standards, ensures that we consistently bring groundbreaking treatments to market.